Anwendung von tissue-microarrays für die diagnose, prognose und therapie-entscheidung beim nierenzellkarzinom

Translated title of the contribution: Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma

A. S. Merseburger*, J. Hennenlotter, D. Schilling, K. D. Sievert, R. Küfer, M. A. Kuczyk

*Corresponding author for this work
6 Citations (Scopus)

Abstract

The tissue microarray technique (TMA) represents a powerful diagnostic "high-throughput" tool to analyse DNA/RNA or protein alterations in large patient cohorts in a time and cost effective way. This review focuses on the clinical application of TMA in renal cell carcinoma in modern "translational" medicine - "from bench to bedside". In particular, the advantages of TMA for diagnosis, prognosis and decisions for therapy will be considered in relation to renal cell cancer.

Translated title of the contributionApplication of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma
Original languageGerman
JournalUrologe - Ausgabe A
Volume45
Issue number3
Pages (from-to)323-327
Number of pages5
ISSN0340-2592
DOIs
Publication statusPublished - 03.2006

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

Fingerprint

Dive into the research topics of 'Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma'. Together they form a unique fingerprint.

Cite this